Medesis Pharma SA Cash Flow-to-Debt Ratio
Medesis Pharma SA cash flow-to-debt ratio. Medesis Pharma SA (ALMDP) has a Cash Flow-to-Debt Ratio of 0.06x as of December 2020, meaning its operating cash flow of €185.83K could theoretically repay 0% of its total liabilities (€2.92 Million) in one year. See ALMDP financial flexibility score to measure the company's free cash flow as a share of total liabilities.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Cash Flow-to-Debt Ratio of Medesis Pharma SA (2019–2020)
Cash flow-to-debt ratio of Medesis Pharma SA from 2019 to 2020. Historical debt coverage capacity for Medesis Pharma SA across 2 annual periods. Check cash flow reinvestment rate of Medesis Pharma SA to assess the company's total reinvestment commitment from operating cash flow.
Medesis Pharma SA Cash Flow-to-Debt Ratio by Year (2019–2020)
Medesis Pharma SA cash flow-to-debt ratio by year from 2019 to 2020. Year-by-year debt coverage analysis for Medesis Pharma SA. For the full cash flow conversion analysis, see ALMDP operating cash flow.
| Year | CF-to-Debt Ratio | Operating CF (EUR) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2020 | 0.06x | €185.83K | €2.92 Million | ▼ -40.3% |
| 2019 | 0.11x | €333.76K | €3.13 Million | — |